Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers

Steroids

Volumn , Issue Part A, 2015, Pages 8-10

  Brown, Susan B ^a   Hankinson, Susan E ^a,b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Breast cancer; Endogenous hormones; Endometrial cancer; Estrogens; Ovarian cancer

Indexed keywords

ESTRADIOL; ESTROGEN; PROGESTERONE;

BREAST CANCER; CANCER RISK; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ENVIRONMENTAL FACTOR; ESTRADIOL BLOOD LEVEL; FOLLOW UP; HUMAN; MENSTRUAL CYCLE; OVARY CANCER; POSTMENOPAUSE; REVIEW; BLOOD; BODY MASS; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; METABOLISM; OVARIAN NEOPLASMS; RISK FACTOR;

BODY MASS INDEX; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; OVARIAN NEOPLASMS; POSTMENOPAUSE; RISK FACTORS;

EID: 84929961472     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2014.12.013     Document Type: Review

References (45)

1. B.E. Henderson, and H.S. Feigelson Hormonal carcinogenesis Carcinogenesis 21 2000 427 433
2. S. Ho Estrogen, progesterone, and epithelial ovarian cancer Reprod Biol Endocrinol 7 1 2003 73
3. W. Yue, J.D. Yager, J.P. Wang, E.R. Jupe, and R.J. Santen Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis Steroids 78 2 2013 161 170
4. C.E. Caldon Estrogen signaling and the DNA damage response in hormone dependent breast cancers Front Oncol 14 4 2014 106
5. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer Lancet 350 1997 1047 1059
6. Collaborative Group on Hormonal Factors in Breast Cancer Menarche, menopause, and breast cancer risk: individual participant meta-analysis including 118,964 women with breast cancer from 117 epidemiological studies Lancet Oncol 13 2012 1141 1151
7. V.W. Setiawan, H.P. Yang, M.C. Pike, S.E. McCann, H. Yu, and Y.B. Xiang Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31 20 2013 2607 2618
8. J. Hunn, and G.C. Rodriguez Ovarian cancer: etiology, risk factors, and epidemiology Clin Obstet Gynecol 55 1 2013 3 23
9. L.M. Morimoto, E. White, Z. Chen, R.T. Chlebowski, J. Hays, and L. Kuller Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States) Cancer Causes Control 13 2002 741 751
10. Endogenous Hormones and Breast Cancer Collaborative Group Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women J Natl Cancer Inst 95 16 2003 1218 1226
11. T.J. Key, P.N. Appleby, G.K. Reeves, A. Roddam, J.F. Dorgan, and C. Longcope Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women J Natl Cancer Inst 95 16 2003 1218 1226
12. V. Beral Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427
13. J. Cuzick, I. Sestak, M. Dowsett, J. Knox, S. Cawthorn, and C. Saunders Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomized placebo-controlled trial Lancet 383 9922 2014 1041 1048
14. M. Dowsett, J. Cuzick, J. Ingle, A. Coates, J. Forbes, and J. Bliss Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen J Clin Oncol 28 3 2010 509 518
15. J. Cuzick, I. Sestak, M. Baum, A. Buzdar, A. Howell, and M. Dowsett Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial Lancet Oncol 11 12 2010 1135 1141
16. Endogenous Hormones and Breast Cancer Collaborative Group Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J Natl Cancer Inst 94 8 2002 606 616
17. J. Manjer, R. Johansson, G. Berglund, L. Janzon, R. Kaaks, and A. Agren Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin, and SHBG Cancer Causes Control 14 7 2003 599 607
18. A. Zeleniuch-Jacquotte, R.E. Shore, K.L. Koenig, A. Akhmedkhanov, Y. Afanasyeva, and I. Kato Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study Br J Cancer 90 1 2004 153 159
19. R. Kaaks, S. Rinaldi, T.J. Key, F. Berrino, P.H. Peeters, and C. Biessy Postmenopausal serum androgens, oestrogens, and breast cancer risk: the European prospective investigation into cancer and nutrition Endocr Relat Cancer 12 4 2005 1071 1082
20. M.J. Gunter, D.R. Hoover, H. Yu, S. Wassertheil-Smoller, and T.E. Rohan Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women J Natl Cancer Inst 101 1 2009 48 60
21. S. Sieri, V. Krogh, G. Bolelli, C.A. Abagnato, S. Grioni, and V. Pala Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort Cancer Epidemiol Biomarkers Prev 18 1 2009 169 176
22. C.G. Woolcott, Y.B. Shvetsov, F.Z. Stanczyk, L.R. Wilkens, K.K. White, and C. Caberto Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study Endocr Relat Cancer 17 1 2010 125 134
23. L. Baglietto, G. Severi, D.R. English, K. Krishnan, J.L. Hopper, and C. McLean Circulating steroid hormone levels and risk of breast cancer for postmenopausal women Cancer Epidemiol Biomarkers Prev 19 2 2010 492 502
24. B.J. Fuhrman, C. Schairer, M.H. Gail, J. Boyd-Morin, X. Xu, and L.Y. Sue Estrogen metabolism and risk of breast cancer in postmenopausal women J Natl Cancer Inst 104 2012 326 339
25. X. Zhang, S.S. Tworoger, A.H. Eliassen, and S.E. Hankinson Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up Breast Cancer Res Treat 137 3 2013 883 892
26. K.J. Helzlsouer, A.J. Alberg, T.L. Bush, C. Longcope, G.B. Gordon, and G.W. Comstock A prospective study of endogenous hormones and breast cancer Cancer Detect Prev 18 2 1994 79 85
27. H.V. Thomas, T.J. Key, D.S. Allen, J.W. Moore, M. Dowsett, and I.S. Fentiman A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey Br J Cancer 75 7 1997 1075 1079
28. A. Micheli, P. Muti, G. Secreto, V. Krogh, E. Meneghini, and E. Venturelli Endogenous sex hormones and subsequent breast cancer in premenopausal women Int J Cancer 112 2 2004 312 318
29. J.F. Dorgan, F.Z. Stanczyk, L.L. Kahle, and L.A. Brinton Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk Breast Cancer Res 12 6 2010 R98
30. R.T. Fortner, A.H. Eliassen, D. Spiegelman, W.C. Willett, R.L. Barbieri, and S.E. Hankinson Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II Breast Cancer Res 15 2013 R19
31. Endogenous Hormones and Breast Cancer Collaborative Group Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies Lancet Oncol 14 2013 1009 1019
32. R. Kaaks, K. Tikk, D. Sookthai, H. Schock, T. Johnson, and A. Tjønneland Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort Int J Cancer 134 8 2014 1947 1957
33. E. Weiderpass, H.O. Adami, J.A. Baron, C. Magnusson, R. Bergstrom, and A. Lindgren Risk of endometrial cancer following estrogen replacement with and without progestins J Natl Cancer Inst 91 1999 1131 1137
34. R. Kaaks, A. Lukanova, and M.S. Kurzer Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review Cancer Epidemiol Biomarkers Prev 11 12 2002 1531 1543
35. N.E. Allen, K.K. Tsilidis, T.J. Key, L. Dossus, R. Kaaks, and E. Lund Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition Am J Epidemiol 172 12 2010 1394 1403
36. S. Karageorgi, S.E. Hankinson, P. Kraft, and I. De Vivo Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004 Int J Cancer 126 1 2010 208 216
37. E.K. Amankwah, C.M. Friedenreich, A.M. Magliocco, R. Brant, K.S. Courneya, and T. Speidel Anthropometric measures and the risk of endometrial cancer, overall and by tumor microsatellite status and histological subtype Am J Epidemiol 177 12 2013 1378 1387
38. A. Lukanova, and R. Kaaks Endogenous hormones and ovarian cancer: epidemiology and current hypotheses Cancer Epidemiol Biomarkers Prev 14 1 2005 98 107
39. N.E. Allen, T.J. Key, L. Dossus, S. Rinaldi, A. Cust, and A. Lukanova Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC) Endocr Relat Cancer 15 2008 485 497
40. M.J. Gunter, D.R. Hoover, H. Yu, S. Wassertheil-Smoller, J.E. Manson, and J. Li A prospective evaluation of insulin and insulin-like growth factor I as risk factors for endometrial cancer Cancer Epidemiol Biomarkers Prev 17 4 2008 921 929
41. K.N. Danforth, S.S. Tworoger, J.L. Hecht, B.A. Rosner, G.A. Colditz, and S.E. Hankinson A prospective study of postmenopausal hormone use and ovarian cancer risk BJC 96 2007 151 156
42. V. Beral Million Women Study Collaborators. Ovarian cancer and hormone-replacement therapy in the Million Women Study Lancet 369 2007 1703 1710
43. M.F. Leitzmann, C. Koebnick, K.N. Danforth, L.A. Brinton, S.C. Moore, and A.R. Hollenbeck Body mass index and risk of ovarian cancer Cancer 115 4 2009 812 822
44. L.S. Mørch, E. Løkkegaard, A.H. Andreasen, S. Krüger-Kjaer, and O. Lidegaard Hormone therapy and ovarian cancer JAMA 302 3 2009 298 305
45. K.J. Helzlsouer, A.J. Alberg, G.B. Gordon, C. Longcope, T.L. Bush, S.C. Hoffman, and G.W. Comstock Serum gonadotropins and steroid hormones and the development of ovarian cancer JAMA 274 24 1995 1926 1930